Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and... - 14 June 2021 20:00

GAITHERSBURG, Md., June 14, 2021 /PRNewswire-AsiaNet/ -- -- 93% efficacy against predominantly circulating Variants of Concern and Variants of Interest -- 91% efficacy in high-risk populations -- 100% efficacy against variants "not considered Variants of Concern/Interest" -- All C...

  Viraleze registered for sale in Covid-ravaged India - 11 June 2021 18:03

MELBOURNE, Australia, June 11, 2021/PRNewswire-AsiaNet/-- India's vast population will have access from today to the Australian developed anti-COVID nasal spray Viraleze™ following its registration in the country. The announcement came as the world's second most populous country battles a devastating ...

  Long-lasting Chlorine Dioxide (ClO2) Aqueous Solution Presente... - 11 June 2021 16:00

OSAKA, Japan, June 11, 2021 /Kyodo JBN-AsiaNet/--- - Solution Also Effective against Alpha and Gamma Variants of SARS-CoV-2 - Taiko Pharmaceutical Co., Ltd. based in Osaka, Japan, hereby announced that long-lasting chlorine dioxide (ClO2) aqueous solution (*1) inactivated over 99.99% of SARS-Co...

  INOVIO Expands Partnership with Advaccine to Conduct Global Ph... - 09 June 2021 15:21

PLYMOUTH MEETING, Pa., June 8, 2021 /PRNewswire-AsiaNet/ -- -- Phase 3 efficacy trial planned to commence this summer in areas of the world underserved by vaccines -- News follows recently announced Phase 2 data, which showed INO-4800 to be well-tolerated and immunogenic in all age gro...

  Inspiring Women's Healthcare: Mindray Unveils Nuewa I9, a New ... - 08 June 2021 18:21

SHENZHEN, China, June 8, 2021 /PRNewswire-AsiaNet/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has introduced the Nuewa I9, its latest cart-based ultrasound system and tailored solution for Obstetrics and Gynecology (OB/GYN). Committed to inspi...

  TargEDys announces the publication of the first double-blind, ... - 08 June 2021 16:31

LONGJUMEAU, France, June 08, 2021 /PRNewswire-AsiaNet/ -- The French biotech TargEDys specialized in breakthrough microbiome-based solutions announces the publication of its study conducted in 230 overweight adults supplemented for 12 weeks, confirming the efficacy of the precision probiotic Hafnia a...

  Copan strengthens its operations in the Americas with a millio... - 08 June 2021 16:00

BRESCIA, Italy, June 8, 2021 /PRNewswire-AsiaNet/ -- Copan announces a $78 million investment to expand its Puerto Rican production site. The project – partially financed by Puerto Rico's Government – will bring Copan production and distribution capacity closer to the American market, strengthening ...

  Second Global Health Forum of Boao Forum for Asia: A Call for ... - 08 June 2021 00:04

QINGDAO, China, June 7, 2021 /PRNewswire-AsiaNet/ -- *An inspiring discussion on international COVID-19 vaccine cooperation Over 1,500 experts, scholars, government medical officials, and representatives of non-government organizations and pharmaceutical companies convened in Qingdao for the seco...

  RedHill Biopharma Completes Enrollment of Oral Opaganib Phase ... - 07 June 2021 22:00

TEL AVIV, Israel and RALEIGH, NC, June 7, 2021, /PRNewswire-AsiaNet/-- - The global Phase 2/3 study of orally-administered opaganib for the treatment of severe COVID-19 enrolled a total of 475 patients, more than the planned 464 - Opaganib is uniquely positioned as a leading novel, dual-action, investigational CO...

  L'OCCITANE Race for Vision 2021: United Against Blindness - 07 June 2021 19:52

GENEVA, June 7, 2021, /PRNewswire-AsiaNet/-- Every year since 2016, the Race for Vision has brought together thousands of L'OCCITANE Group employees across the world. Its aim is to fight blindness in countries where many cases of vision loss could be prevented with appropriate screening or t...